All lobbying filings

MYRIAD GENETICS, INC.

MYRIAD GENETICS, INC. filed a Q4 report for MYRIAD GENETICS, INC. on January 20, 2026.

Lobbying for MYRIAD GENETICS, INC.

All filings by MYRIAD GENETICS, INC. · Everything MYRIAD GENETICS, INC. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Expenses

$250,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Congressional oversight of Medicare Advantage and prior authorization issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.